ATC level 4
S01XAEye medicines, subgroup S01X, subgroup S01XA
- Molecules
- 14
- Subgroups
- 13
ATC S01XA (Eye medicines, subgroup S01X, subgroup S01XA) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 14 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
- S01XA08Acetylcysteine1
- S01XA13Alteplase1
- S01XA14Heparin1
- S01XA15Ascorbic acid1
- S01XA18Cyclosporine1
- S01XA19Ex vivo expanded autologous human corneal epithelial cells containing stem cells1
- S01XA21Mercaptamine2
- S01XA23Sirolimus1
- S01XA24Cenegermin1
- S01XA25Lifitegrast1
- S01XA27Voretigene neparvovec1
- S01XA31Pegcetacoplan1
- S01XA32Avacincaptad pegol1
Molecules
Molecules with an ATC code under S01XA.
- AcetylcysteineOrphanAntidote8 presentations1 brandR05CB01
- AlteplaseBiologic2 presentations2 brandsB01AD02
- Ascorbic acidOrphanVitamin C4 presentations1 brandA11GA01
- Avacincaptad pegolComplement Inhibitor1 presentation1 brandS01XA32
- CenegerminOrphanRecombinant Human Nerve Growth Factor2 presentations2 brandsS01XA24
- CyclosporineOrphanCalcineurin Inhibitor Immunosuppressant25 presentations13 brandsL04AD01
- CysteamineOrphanCystine Depleting Agent8 presentations4 brandsA16AA04
- Ex vivo expanded autologous human corneal epithelial cells containing stem cellsBiologic1 brandS01XA19
- HeparinAnti-coagulant7 presentationsB01AB01
- LifitegrastLymphocyte Function-Associated Antigen-1 Antagonist2 presentations1 brandS01XA25
- MercaptamineOrphan3 brandsA16AA04
- PegcetacoplanOrphanComplement Inhibitor2 presentations3 brandsL04AJ03
- SirolimusOrphanKinase Inhibitor6 presentations4 brandsL04AH01
- Voretigene neparvovecOrphan1 presentation2 brandsS01XA27
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.